IGC Pharma, Inc.
₺13.11
TRY
Last updated on --.
24h volume321.73K
24h highest13.3909 TRY
24h lowest12.7839 TRY
24h Price movement-0.97%
IGC recent prices
24 Hours
-0.97%-₺0.12876
30 days
-9.74%-₺1.435
60 days
+12.81%+₺1.503
90 days
+1.47%+₺0.19314
Key data
Previous close13.2438 TRY
Market cap1.28B TRY
Volume321.73K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.2190 TRY
Net income (FY)-304.33M TRY
Revenue (FY)53.71M TRY
Last report dateMay 15, 2026
About IGC Pharma, Inc.
HeadquartersPOTOMAC
Employees (FY)70.00
Revenue per employee (FY)767.30K TRY
Net income per employee (FY)-4.35M TRY
Listed onXASE
IGC conversion tables
 |  |
|---|---|
| 0.5 IGC | 6.557 TRY |
| 1 IGC | 13.11 TRY |
| 5 IGC | 65.57 TRY |
| 10 IGC | 131.15 TRY |
| |
|---|---|
| 0.5 TRY | 0.038124 IGC |
| 1 TRY | 0.076248 IGC |
| 5 TRY | 0.38124 IGC |
| 10 TRY | 0.76248 IGC |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
IGC is trading at ₺13.11, -0.97% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IGC stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IGC is currently trading at ₺13.11, -0.97% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IGC price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IGC's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IGC; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IGC's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
IGC Pharma, Inc.'s market cap is currently 1.28B TRY. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX TR does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX TR. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX TR does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX TR does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume321.73K
24h highest13.3909 TRY
24h lowest12.7839 TRY
24h Price movement-0.97%
Start trade with IGC Perpetual
Sign up to trade